Search for a mass chemotherapeutic drug for cholera control. A study of Vibrio excretion following single and multiple dose treatment.
- 1 January 1966
- journal article
- research article
- Vol. 35 (5) , 669-74
Abstract
In a study designed to seek a suitable drug for mass chemotherapy during a cholera epidemic, four drugs were administered in single doses to patients with cholera in Iran. Streptomycin was administered orally; penicillin, parenterally; and chloramphenicol and a long-acting sulfa drug, both orally and parenterally. No drug consistently eliminated vibrios from the intestinal tract. Chloramphenicol was also administered in multiple doses for three days; this also failed to eliminate vibrios in one-third of 25 patients studied. The major problem with these drugs administered orally seems to be rapid elimination and poor absorption by patients with diarrhoea. The authors do not recommend any of these drugs for single-dose mass chemotherapy and consider that chloramphenicol cannot be recommended for multiple-dose mass chemotherapy.This publication has 9 references indexed in Scilit:
- Detection of Vibrio cholerae biotype El Tor by purging.1966
- TETRACYCLINE IN THE TREATMENT OF CHOLERAThe Lancet, 1964
- TETRACYCLINE THERAPY IN CHOLERA.1964
- A New Selective Isolation Medium for the Vibrio GroupNippon Saikingaku Zasshi, 1963
- A highly selective gelatin-taurocholate-tellurite medium for the isolation of Vibrio choleraeTransactions of the Royal Society of Tropical Medicine and Hygiene, 1961
- Interactions of Vibrio cholerae, Shigella flexneri, Enterococci, and Lactobacilli in Continuously Fed CulturesExperimental Biology and Medicine, 1961
- The Nature of the Gastrointestinal Lesion in Asiatic Cholera and Its Relation to Pathogenesis: A Biopsy StudyThe American Journal of Tropical Medicine and Hygiene, 1960
- COPROANTIBODY AND BACTERIAL ANTAGONISM AS PROTECTIVE FACTORS IN EXPERIMENTAL ENTERIC CHOLERAThe Journal of Experimental Medicine, 1956